clonidine has been researched along with Neurodevelopmental Disorders in 2 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zammit, J | 3 |
| Ferrafiat, V | 3 |
| Bang Madsen, K | 1 |
| Robakis, TK | 1 |
| Liu, X | 1 |
| Momen, N | 1 |
| Larsson, H | 1 |
| Dreier, JW | 1 |
| Kildegaard, H | 1 |
| Groth, JB | 1 |
| Newcorn, JH | 1 |
| Hove Thomsen, P | 1 |
| Munk-Olsen, T | 1 |
| Bergink, V | 1 |
2 other studies available for clonidine and Neurodevelopmental Disorders
| Article | Year |
|---|---|
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
In utero exposure to ADHD medication and long-term offspring outcomes.
Topics: Adult; Amphetamines; Attention Deficit Disorder with Hyperactivity; Child, Preschool; Clonidine; Coh | 2023 |